|
1
|
Lee JH, Kim JG, Jung HK, Kim JH, Jeong WK,
Jeon TJ, Kim JM, Kim YI, Ryu KW, Kong SH, et al: Clinical practice
guidelines for gastric cancer in Korea: An evidence-based approach.
J Gastric Cancer. 14:87–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Long ZW, Yu HM, Wang YN, Liu D, Chen YZ,
Zhao YX and Bai L: Association of IL-17 polymorphisms with gastric
cancer risk in Asian populations. World J Gastroenterol.
21:5707–5718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen XZ, Chen H, Castro FA, Hu JK and
Brenner H: Epstein-Barr virus infection and gastric cancer: a
systematic review. Medicine (Baltimore). 94:e7922015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kanaan Z, Rai SN, Eichenberger MR, Roberts
H, Keskey B, Pan J and Galandiuk S: Plasma miR-21: a potential
diagnostic marker of colorectal cancer. Ann Surg. 256:544–551.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li T, Li RS, Li YH, Zhong S, Chen YY,
Zhang CM, Hu MM and Shen ZJ: miR-21 as an independent biochemical
recurrence predictor and potential therapeutic target for prostate
cancer. J Urol. 187:1466–1472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ,
Wang YK, Zeng F, Zhou JH and Zhang YK: High expression of serum
miR-21 and tumor miR-200c associated with poor prognosis in
patients with lung cancer. Med Oncol. 29:618–626. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han M, Wang Y, Liu M, Bi X, Bao J, Zeng N,
Zhu Z, Mo Z, Wu C and Chen X: MiR-21 regulates
epithelial-mesenchymal transition phenotype and hypoxia-inducible
factor-1α expression in third-sphere forming breast cancer stem
cell-like cells. Cancer Sci. 103:1058–1064. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lakomy R, Sana J, Hankeova S, Fadrus P,
Kren L, Lzicarova E, Svoboda M, Dolezelova H, Smrcka M, Vyzula R,
et al: MiR-195, miR-196b, miR-181c, miR-21 expression levels and
O-6-methylguanine-DNA methyltransferase methylation status are
associated with clinical outcome in glioblastoma patients. Cancer
Sci. 102:2186–2190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu QL, Abel P, Foster CS and Lalani EN:
bcl-2: role in epithelial differentiation and oncogenesis. Hum
Pathol. 27:102–110. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luanpitpong S, Chanvorachote P, Stehlik C,
Tse W, Callery PS, Wang L and Rojanasakul Y: Regulation of
apoptosis by Bcl-2 cysteine oxidation in human lung epithelial
cells. Mol Biol Cell. 24:858–869. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Flangea C, Potencz E, Mihăescu R, Gîju S
and Anghel A: Bcl-2 expression in Hodgkin's lymphoma progression.
Rom J Morphol Embryol. 49:357–363. 2008.PubMed/NCBI
|
|
12
|
Manne U, Weiss HL and Grizzle WE: Bcl-2
expression is associated with improved prognosis in patients with
distal colorectal adenocarcinomas. Int J Cancer. 89:423–430. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou XL and Wang M: Expression levels of
survivin, Bcl-2, and KAI1 proteins in cervical cancer and their
correlation with metastasis. Genet Mol Res. 14:17059–17067. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hajnóczky G, Csordás G, Das S,
Garcia-Perez C, Saotome M, Sinha Roy S and Yi M: Mitochondrial
calcium signalling and cell death: approaches for assessing the
role of mitochondrial Ca2+ uptake in apoptosis. Cell
Calcium. 40:553–560. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shimamoto S, Tsuchiya M, Yamaguchi F,
Kubota Y, Tokumitsu H and Kobayashi R: Ca2+/S100
proteins inhibit the interaction of FKBP38 with Bcl-2 and Hsp90.
Biochem J. 458:141–152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Yimamu M, Wang X, Zhang X, Mao M, Fu
L, Aisimitula A, Nie Y and Huang Q: Addition of rituximab to a CEOP
regimen improved the outcome in the treatment of non-germinal
center immunophenotype diffuse large B cell lymphoma cells with
high Bcl-2 expression. Int J Hematol. 99:79–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Simsek EN and Uysal T: In vitro
investigation of cytotoxic and apoptotic effects of Cynara L.
species in colorectal cancer cells. Asian Pac J Cancer Prev.
14:6791–6795. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo KW, Ko CH, Yue GGL, Lee JK, Li KK, Lee
M, Li G, Fung KP, Leung PC and Lau CB: Green tea (Camellia
sinensis) extract inhibits both the metastasis and osteolytic
components of mammary cancer 4T1 lesions in mice. J Nutr Biochem.
25:395–403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu CJ, Zhou L and Cai Y:
Dihydroartemisinin induces apoptosis of cervical cancer cells via
upregulation of RKIP and downregulation of bcl-2. Cancer Biol Ther.
15:279–288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pushkarev VM, Kovzun OI, Pushkarev VV and
Tronko M: Biochemical effects of combined action of γ-irradiation
and paclitaxel on anaplastic thyroid cancer cells. Ukr Biokhim Zh
(1999). 85:51–61. 2013.PubMed/NCBI
|
|
21
|
Banzhaf-Strathmann J and Edbauer D: Good
guy or bad guy: the opposing roles of microRNA 125b in cancer. Cell
Commun Signal. 12:302014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lim L, Balakrishnan A, Huskey N, Jones KD,
Jodari M, Ng R, Song G, Riordan J, Anderton B, Cheung ST, et al:
MicroRNA-494 within an oncogenic microRNA megacluster regulates
G1/S transition in liver tumorigenesis through suppression of
mutated in colorectal cancer. Hepatology. 59:202–215. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Melo SA, Sugimoto H, O'Connell JT, Kato N,
Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, et
al: Cancer exosomes perform cell-independent microRNA biogenesis
and promote tumorigenesis. Cancer Cell. 26:707–721. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kasinski AL, Kelnar K, Stahlhut C,
Orellana E, Zhao J, Shimer E, Dysart S, Chen X, Bader AG and Slack
FJ: A combinatorial microRNA therapeutics approach to suppressing
non-small cell lung cancer. Oncogene. 34:3547–3555. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meng F, Henson R, Lang M, Wehbe H,
Maheshwari S, Mendell JT, Jiang J, Schmittgen TD and Patel T:
Involvement of human micro-RNA in growth and response to
chemotherapy in human cholangiocarcinoma cell lines.
Gastroenterology. 130:2113–2129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lund E, Güttinger S, Calado A, Dahlberg JE
and Kutay U: Nuclear export of microRNA precursors. Science.
303:95–98. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Asangani IA, Rasheed SAK, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Frankel LB, Christoffersen NR, Jacobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
